Comparison of the Structure and DNA-binding Properties of the E2 Proteins from an Oncogenic and a Non-oncogenic Human Papillomavirus

Journal of Molecular Biology

Volumn 334, Issue 5, 2003, Pages 979-991

  Dell, Ghislaine ^a   Wilkinson, Kay W ^a   Tranter, Rebecca ^a   Parish, Joanna ^a,b   Brady, R Leo ^a   Gaston, Kevin ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

DNA binding; DNA conformation; E2 protein; Papillomavirus; Sequence specificity

Indexed keywords

ADENINE NUCLEOTIDE; NITROGEN DERIVATIVE; PYRIMIDINE NUCLEOTIDE; VIRUS PROTEIN;

ARTICLE; BASE PAIRING; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; WART VIRUS;

BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0345304716     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.10.009     Document Type: Article

References (36)

1. Dell G., Gaston K. Human papillomaviruses and their role in cervical cancer. Cell Mol. Life Sci. 58:2001;1923-1942.
2. Hegde R.S. The papillomavirus E2 proteins: structure, function, and biology. Annu. Rev. Biophys. Biomol. Struct. 31:2002;343-360.
3. Giri Y., Yaniv M. Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J. 7:1988;2823-2829.
4. Antson A.A., Burns J.E., Moroz O.V., Scott D.J., Sanders C.M., Bronstein I.B., et al. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature. 403:2000;805-809.
5. Harris S.F., Botchan M.R. Crystal structure of the human papillomavirus type 18 E2 activation domain. Science. 284:1999;1673-1677.
6. Hegde R.S., Androphy E.J. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA-binding-site selection mechanism. J. Mol. Biol. 284:1998;1479-1489.
7. Kim S.-S., Tam J.K., Wang A.-F., Hegde R.S. The structural basis of DNA target discrimination by papillomavirus E2 proteins. J. Biol. Chem. 275:2000;31245-31254.
8. Bussiere D.E., Kong X., Egan D.A., Walter K., Holzman T.F., Lindh F., et al. Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 Å Acta Crystallog. sect. D. 54:1998;1367-1376.
9. Hegde R.S., Grossman S.R., Laimins L., Sigler P.B. Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature. 359:1992;505-512.
10. Pepinsky R.B., Prakash S.S., Corina K., Grossel M.J., Barsoum J., Androphy E.J. Sequences flanking the core DNA-binding domain of bovine papillomavirus type 1 E2 contribute to DNA-binding function. J. Virol. 71:1997;828-831.
11. Li R., Knight J., Bream G., Stenlund A., Botchan M. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev. 3:1989;510-526.
12. Hines C.S., Meghoo C., Shetty S., Biburger M., Brenowitz M., Hegde R. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. J. Mol. Biol. 276:1998;809-818.
13. Thain A., Webster K., Emery D., Clarke A.R., Gaston K. DNA binding and bending by the human papillomavirus type 16 E2 protein. J. Biol. Chem. 272:1997;8236-8242.
14. Meyers G., Bernard H.U., Delius H., Baker C., Icenogle J., Halpern A., et al. Human Papillomaviruses, 1995 Compendium. 1995;Los Alamos National Laboratory, Los Alamos, NM.
15. Bernard B.A., Bailly C., Lenoir M.C., Darman M., Thierry F., Yaniv M. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV 18 regulatory region in human keratinocytes. J. Virol. 63:1989;4317-4324.
16. Bouvard V., Storey A., Pim D., Banks L. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J. 13:1994;5451-5459.
17. Bouvard V., Thierry F., Howley P.M. Characterisation of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J. 13:1994;5451-5459.
18. Sanders C.M., Maitland N.J. Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements. Nucl. Acids Res. 22:1994;4890-4897.
19. Alexander K.A., Phelps W.C. A fluorescence anisotropy study of DNA binding by HPV-11 E2C protein: a hierarchy of E2-binding sites. Biochemistry. 35:1996;9864-9872.
20. Spalholz B.A., Byrne J.C., Howley P.M. Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1. J. Virol. 62:1988;3143-3150.
21. Knight J.D., Li R., Botchan M. The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops. Proc. Natl Acad. Sci. USA. 88:1991;3204-3208.
22. Tan S.-H., Gloss B., Bernard H.-U. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from proximal promoter element. Nucl. Acids Res. 20:1992;251-256.
23. Tan S.-H., Leong L.E.-C., Walker P.A., Bernard H.-U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68:1994;6411-6420.
24. Zinkel S.S., Crothers D.M. DNA bend direction by phase sensitive detection. Nature. 328:1987;178-181.
25. Packer M.J., Dauncey M.P., Hunter C.A. Sequence-dependent DNA structure: tetranucleotide conformational maps. J. Mol. Biol. 295:2000;85-103.
26. Zimmerman J.M., Maher L.J. III. Solution measurement of DNA curvature in papillomavirus E2 binding sites. Nucl. Acids Res. 31:2003;5134-5139.
27. Lewis H., Webster K., Sanchez-Perez A.M., Gaston K. Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein. J. Gen. Virol. 80:1999;2087-2096.
28. Koudelka G.B., Carlson P. DNA twisting and the effects of non-contacted bases on affinity of 434 operator for 434 repressor. Nature. 355:1992;89-91.
29. Gaston K., Kolb A., Busby S. Binding of the Escherichia coli cyclic AMP receptor protein to DNA fragments containing consensus nucleotide sequences. Biochem. J. 261:1989;649-653.
30. Kovelman R., Bilter G.K., Glezer E., Tsou A.Y., Barbosa M.S. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J. Virol. 70:1996;7549-7560.
31. Hou S.Y., Wu S.Y., Chiang C.M. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding. J. Biol. Chem. 277:2002;45619-45629.
32. Otwinowski Z. Sawyer L. Proceedings of the Daresbury Study Weekend. DENZO and SCALEPACK - Data processing and scaling programes. 1993;Daresbury Laboratory, Warrington, UK.
33. Nicholls A., Sharp K.A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:1991;281-296.
34. Thompson J.F., Landy A. Empirical estimation of protein-induced DNA bending angles: applications to lambda site-specific recombination complexes. Nucl. Acids Res. 16:1988;9687-9705.
35. Spassky A., Busby S., Buc H. On the action of the cyclic AMP-cyclic AMP receptor protein complex at the Escherichia coli lactose and galactose promoter regions. EMBO J. 3:1984;43-50.
36. Tullius T.D., Dombroski B.A. Hydroxyl radical "footprinting" high resolution information about DNA-protein contacts and application to lambda repressor and Cro protein. Proc. Natl Acad. Sci. USA. 83:1986;5469-5473.